Obsidio
Columbia
About Obsidio
Obsidio, Inc. is an early-stage medical device company pioneering a biomaterial platform technology to enable minimally-invasive occlusion of blood vessels anywhere in the body regardless of the patient’s coagulopathy. The technology can be used to control bleeding, close off vessels supplying blood to tumor, eliminate abnormal connections between arteries and veins, and treat aneurysms.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $4.8M
- Funding stage: M&A
- Last round: Seed (Aug 2020)
- Website: obsidiomed.com
- Phone: [email protected]
Industries & Categories
Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/obsidio-112198 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.